Importer of Controlled Substances Registration, 66750-66751 [2018-28078]
Download as PDF
<![CDATA[
66750
Federal Register / Vol. 83, No. 247 / Thursday, December 27, 2018 / Notices
Dated: December 11, 2018.
Uttam Dhillon,
Acting Administrator.
[FR Doc. 2018–28072 Filed 12–26–18; 8:45 am]
BILLING CODE 4410–09–P
DEPARTMENT OF JUSTICE
Drug Enforcement Administration
[Docket No. DEA–392]
Importer of Controlled Substances
Application: Johnson Matthey Inc.
ACTION:
Written comments should
be sent to: Drug Enforcement
Administration, Attention: DEA Federal
Register Representative/DPW, 8701
Morrissette Drive, Springfield, Virginia
22152. All requests for hearing must be
sent to: Drug Enforcement
Administration, Attn: Administrator,
8701 Morrissette Drive, Springfield,
Virginia 22152. All requests for hearing
should also be sent to: (1) Drug
Enforcement Administration, Attn:
Hearing Clerk/OALJ, 8701 Morrissette
Drive, Springfield, Virginia 22152; and
(2) Drug Enforcement Administration,
Attn: DEA Federal Register
Representative/DPW, 8701 Morrissette
Drive, Springfield, Virginia 22152.
Comments and requests for hearings on
applications to import narcotic raw
material are not appropriate. 72 FR
3417, (January 25, 2007)
ADDRESSES:
Notice of application.
Registered bulk manufacturers of
the affected basic classes, and
applicants therefore, may file written
comments on or objections to the
issuance of the proposed registration on
or before January 28, 2019. Such
persons may also file a written request
for a hearing on the application on or
before January 28, 2019.
DATES:
SUPPLEMENTARY INFORMATION:
The Attorney General has delegated
his authority under the Controlled
Substances Act to the Administrator of
the Drug Enforcement Administration
(DEA), 28 CFR 0.100(b). Authority to
exercise all necessary functions with
respect to the promulgation and
implementation of 21 CFR part 1301,
incident to the registration of
manufacturers, distributors, dispensers,
importers, and exporters of controlled
substances (other than final orders in
connection with suspension, denial, or
revocation of registration) has been
redelegated to the Assistant
Administrator of the DEA Diversion
Control Division (‘‘Assistant
Administrator’’) pursuant to section 7 of
28 CFR part 0, appendix to subpart R.
In accordance with 21 CFR
1301.34(a), this is notice that on October
15, 2018, Johnson Matthey Inc., 2003
Nolte Drive, West Deptford, New Jersey
08066 applied to be registered as an
importer of the following basic classes
of controlled substances:
Controlled substance
Drug code
Coca Leaves ............................................................................................................................................................
Thebaine ..................................................................................................................................................................
Opium, raw ..............................................................................................................................................................
Noroxymorphone .....................................................................................................................................................
Poppy Straw Concentrate ........................................................................................................................................
Fentanyl ...................................................................................................................................................................
The company plans to import coca
leaves (9040), raw opium (9600), and
poppy straw concentrate (9670) in order
to bulk manufacture active
pharmaceutical ingredients (API) for
distribution to its customers. The
company plans to also import thebaine
(9333), noroxymorophone (9668), and
fentanyl (9801) to use as analytical
reference standards, both internally and
to be sold to their customers to support
testing of Johnson Matthey Inc.’s API’s
only.
Dated: December 8, 2018.
John J. Martin,
Assistant Administrator.
[FR Doc. 2018–28073 Filed 12–26–18; 8:45 am]
khammond on DSK30JT082PROD with NOTICES
BILLING CODE 4410–09–P
DEPARTMENT OF JUSTICE
Company
17:14 Dec 26, 2018
Jkt 247001
II
II
II
II
II
II
FR docket
Published
83 FR
49580.
October
2, 2018.
Drug Enforcement Administration
R & D Systems, Inc.
[Docket No. DEA–392]
The Drug Enforcement
Administration (DEA) has considered
the factors in 21 U.S.C. 823, 952(a) and
958(a) and determined that the
registration of the listed registrant to
import the applicable basic classes of
schedule I or II controlled substances is
consistent with the public interest and
with United States obligations under
international treaties, conventions, or
protocols in effect on May 1, 1971. The
DEA investigated the company’s
maintenance of effective controls
against diversion by inspecting and
testing the company’s physical security
systems, verifying the company’s
compliance with state and local laws,
and reviewing the company’s
background and history.
Therefore, pursuant to 21 U.S.C.
952(a) and 958(a), and in accordance
with 21 CFR 1301.34, the DEA has
granted a registration as an importer for
schedule I or II controlled substances to
the above listed company.
Importer of Controlled Substances
Registration
ACTION:
Notice of registration.
The registrant listed below
has applied for and been granted
registration by the Drug Enforcement
Administration (DEA) as an importer of
various classes of schedule I or II
controlled substances.
SUMMARY:
The
company listed below applied to be
registered as an importer of various
basic classes of controlled substances.
Information on previously published
notices is listed in the table below. No
comments or objections were submitted
and no requests for hearing were
submitted for this notice.
SUPPLEMENTARY INFORMATION:
necessitates that this Order be effective
immediately. 21 CFR 1316.67.
VerDate Sep<11>2014
9040
9333
9600
9668
9670
9801
Schedule
PO 00000
Frm 00080
Fmt 4703
Sfmt 4703
E:\FR\FM\27DEN1.SGM
27DEN1
66751
Federal Register / Vol. 83, No. 247 / Thursday, December 27, 2018 / Notices
Dated: December 8, 2018.
John J. Martin,
Assistant Administrator.
substances (other than final orders in
connection with suspension, denial, or
revocation of registration) has been
redelegated to the Assistant
Administrator of the DEA Diversion
Control Division (‘‘Assistant
Administrator’’) pursuant to section 7 of
28 CFR part 0, appendix to subpart R.
In accordance with 21 CFR
1301.34(a), this is notice that on
November 2, 2018, Myoderm, 48 East
Main Street, Norristown, Pennsylvania
19401–4915 applied to be registered as
an importer of the following basic
classes of controlled substances:
[FR Doc. 2018–28078 Filed 12–26–18; 8:45 am]
BILLING CODE 4410–09–P
DEPARTMENT OF JUSTICE
Drug Enforcement Administration
[Docket No. DEA–392]
Importer of Controlled Substances
Application: Myoderm
ACTION:
Notice of application.
Registered bulk manufacturers of
the affected basic classes, and
applicants therefore, may file written
comments on or objections to the
issuance of the proposed registration on
or before January 28, 2019. Such
persons may also file a written request
for a hearing on the application on or
before January 28, 2019.
ADDRESSES: Written comments should
be sent to: Drug Enforcement
Administration, Attention: DEA Federal
Register Representative/DPW, 8701
Morrissette Drive, Springfield, Virginia
22152. All requests for hearing must be
sent to: Drug Enforcement
Administration, Attn: Administrator,
8701 Morrissette Drive, Springfield,
Virginia 22152. All requests for hearing
should also be sent to: (1) Drug
Enforcement Administration, Attn:
Hearing Clerk/OALJ, 8701 Morrissette
Drive, Springfield, Virginia 22152; and
(2) Drug Enforcement Administration,
Attn: DEA Federal Register
Representative/DPW, 8701 Morrissette
Drive, Springfield, Virginia 22152.
SUPPLEMENTARY INFORMATION: The
Attorney General has delegated his
authority under the Controlled
Substances Act to the Administrator of
the Drug Enforcement Administration
(DEA), 28 CFR 0.100(b). Authority to
exercise all necessary functions with
respect to the promulgation and
implementation of 21 CFR part 1301,
incident to the registration of
manufacturers, distributors, dispensers,
importers, and exporters of controlled
Controlled
substance
DATES:
Drug code
Amphetamine ........
Lisdexamfetamine
Methylphenidate ...
Nabilone ................
Oxycodone ............
Hydromorphone ....
Hydrocodone ........
Morphine ...............
Oxymorphone .......
Fentanyl ................
Schedule
1100
1205
1724
7379
9143
9150
9193
9300
9652
9801
II
II
II
II
II
II
II
II
II
II
The company plans to import the
listed controlled substances for clinical
trials, research, and analytical purposes.
Approval of permit applications will
occur only when the registrant’s activity
is consistent with what is authorized
under to 21 U.S.C.952(a)(2).
Authorization will not extend to the
import of FDA approved or nonapproved finished dosage forms for
commercial sale.
Dated: December 8, 2018.
John J. Martin,
Assistant Administrator.
[FR Doc. 2018–28081 Filed 12–26–18; 8:45 am]
BILLING CODE 4410–09–P
DEPARTMENT OF JUSTICE
Drug Enforcement Administration
[Docket No. DEA–392]
Importer of Controlled Substances
Application: Agilent Technologies
ACTION:
Notice of application.
Registered bulk manufacturers of
the affected basic classes, and
applicants therefore, may file written
comments on or objections to the
issuance of the proposed registration on
or before January 28, 2019. Such
persons may also file a written request
for a hearing on the application on or
before January 28, 2019.
DATES:
Written comments should
be sent to: Drug Enforcement
Administration, Attention: DEA Federal
Register Representative/DPW, 8701
Morrissette Drive, Springfield, Virginia
22152. All requests for hearing must be
sent to: Drug Enforcement
Administration, Attn: Administrator,
8701 Morrissette Drive, Springfield,
Virginia 22152. All requests for hearing
should also be sent to: (1) Drug
Enforcement Administration, Attn:
Hearing Clerk/OALJ, 8701 Morrissette
Drive, Springfield, Virginia 22152; and
(2) Drug Enforcement Administration,
Attn: DEA Federal Register
Representative/DPW, 8701 Morrissette
Drive, Springfield, Virginia 22152.
ADDRESSES:
The
Attorney General has delegated his
authority under the Controlled
Substances Act to the Administrator of
the Drug Enforcement Administration
(DEA), 28 CFR 0.100(b). Authority to
exercise all necessary functions with
respect to the promulgation and
implementation of 21 CFR part 1301,
incident to the registration of
manufacturers, distributors, dispensers,
importers, and exporters of controlled
substances (other than final orders in
connection with suspension, denial, or
revocation of registration) has been
redelegated to the Assistant
Administrator of the DEA Diversion
Control Division (‘‘Assistant
Administrator’’) pursuant to section 7 of
28 CFR part 0, appendix to subpart R.
SUPPLEMENTARY INFORMATION:
In accordance with 21 CFR
1301.34(a), this is notice that on August
13, 2018, Agilent Technologies, 250
Smith Street, North Kingstown, Rhode
Island 02852 applied to be registered as
an importer of the following basic
classes of controlled substances:
khammond on DSK30JT082PROD with NOTICES
Controlled substance
Drug code
Marihuana ................................................................................................................................................................
Tetrahydrocannabinols ............................................................................................................................................
VerDate Sep<11>2014
17:14 Dec 26, 2018
Jkt 247001
PO 00000
Frm 00081
Fmt 4703
Sfmt 4703
E:\FR\FM\27DEN1.SGM
27DEN1
7360
7370
Schedule
I
I
]]>Agencies
[Federal Register Volume 83, Number 247 (Thursday, December 27, 2018)]
[Notices]
[Pages 66750-66751]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2018-28078]
-----------------------------------------------------------------------
DEPARTMENT OF JUSTICE
Drug Enforcement Administration
[Docket No. DEA-392]
Importer of Controlled Substances Registration
ACTION: Notice of registration.
-----------------------------------------------------------------------
SUMMARY: The registrant listed below has applied for and been granted
registration by the Drug Enforcement Administration (DEA) as an
importer of various classes of schedule I or II controlled substances.
SUPPLEMENTARY INFORMATION: The company listed below applied to be
registered as an importer of various basic classes of controlled
substances. Information on previously published notices is listed in
the table below. No comments or objections were submitted and no
requests for hearing were submitted for this notice.
------------------------------------------------------------------------
Company FR docket Published
------------------------------------------------------------------------
R & D Systems, Inc.............. 83 FR 49580....... October 2, 2018.
------------------------------------------------------------------------
The Drug Enforcement Administration (DEA) has considered the
factors in 21 U.S.C. 823, 952(a) and 958(a) and determined that the
registration of the listed registrant to import the applicable basic
classes of schedule I or II controlled substances is consistent with
the public interest and with United States obligations under
international treaties, conventions, or protocols in effect on May 1,
1971. The DEA investigated the company's maintenance of effective
controls against diversion by inspecting and testing the company's
physical security systems, verifying the company's compliance with
state and local laws, and reviewing the company's background and
history.
Therefore, pursuant to 21 U.S.C. 952(a) and 958(a), and in
accordance with 21 CFR 1301.34, the DEA has granted a registration as
an importer for schedule I or II controlled substances to the above
listed company.
[[Page 66751]]
Dated: December 8, 2018.
John J. Martin,
Assistant Administrator.
[FR Doc. 2018-28078 Filed 12-26-18; 8:45 am]
BILLING CODE 4410-09-P
